Decision Making in Advanced Heart Failure
Larry A. Allen(University of Colorado Denver), John A. Spertus(Saint Luke's Health System), Donna Mancini(Mount Sinai Hospital), Kathleen L. Grady(Northwestern University), G. Michael Felker(Clinical Research Institute), Edward P. Havranek(University of Colorado Anschutz Medical Campus), Paul J. Hauptman, Lynne W. Stevenson(Vanderbilt University Medical Center), Bárbara Riegel(California University of Pennsylvania), Nancy R. Cook(Brigham and Women's Hospital), Robert M. Arnold(Icahn School of Medicine at Mount Sinai), Harlan M. Krumholz(Yale New Haven Hospital), Nathan E. Goldstein, Gary S. Francis, Daniel D. Matlock
Cited by 810
Related Papers
Assessing the Performance of Prediction Models
|Epidemiology|2009|4.9k
Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First Cardiovascular Events
|New England Journal of Medicine|2002|3.6k
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
|Journal of the American College of Cardiology|2020|2.9k
Lack of Effect of Long-Term Supplementation with Beta Carotene on the Incidence of Malignant Neoplasms and Cardiovascular Disease
|New England Journal of Medicine|1996|2.4k
C-Reactive Protein, the Metabolic Syndrome, and Risk of Incident Cardiovascular Events
|Circulation|2003|2.3k